- TWD2.83bn
- TWD2.25bn
- TWD716.55m
- 49
- 31
- 22
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 498 | 759 | 746 | 878 | 717 |
Cost of Revenue | |||||
Gross Profit | 152 | 295 | 252 | 344 | 257 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 503 | 620 | 664 | 707 | 645 |
Operating Profit | -4.35 | 140 | 81.9 | 171 | 71.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.466 | 111 | 90.6 | 205 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.441 | 106 | 85 | 176 | 86.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.441 | 106 | 85 | 176 | 86.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0.441 | 106 | 85 | 176 | 86.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | 0.643 | 0.511 | 1.06 | 0.522 |
Dividends per Share |